What is Emme?
Emme is a pioneering healthcare technology company dedicated to empowering women with control over their reproductive health, beginning with birth control. The company's flagship offering, the Emme Smart Case and accompanying app, represents an integrated technological solution designed to enhance the birth control experience and mitigate the issue of missed pills. Leveraging patent-pending multi-sensor technology, the Emme Smart Case meticulously tracks pill consumption. This smart device synchronizes with the Emme app, delivering persistent, personalized reminders until a dose is taken and providing essential contraceptive guidance when necessary. The app further supports users by offering a holistic view of their well-being through cycle, mood, and side effect tracking functionalities. Co-founded in 2017 by Amanda French and Dr. Janene Fuerch, Emme aims to modernize the 21st-century approach to women's health.
How much funding has Emme raised?
Emme has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M, investors not publicly disclosed
What's next for Emme?
With the recent infusion of capital, Emme is poised for significant expansion and further development of its innovative women's health platform. The major strategic investment suggests a focus on scaling operations, enhancing product features, and potentially broadening its market reach. This funding will likely enable Emme to solidify its position in the digital health and femtech sectors, driving forward its mission to provide women with accessible and reliable tools for managing their reproductive health. The company's trajectory indicates a strong commitment to innovation and user-centric design in addressing critical healthcare needs.
See full Emme company page
